GeneDx believes in responsible testing that is based on established medical guidelines, and we aim to be completely transparent with our pricing so that patients, clinicians, and payers know the cost of the test.

This webinar is presented by Maegan E.Roberts, Dr. Wendy Chung and Dr. Mary Beth Terry. This webinar focuses on a recent Genetics in Medicine publication that showed a strong association of breast cancer in patients with a pathogenic variant in Lynch syndrome genes.

This webinar is presented by GeneDx’s Chief Innovation Office, Kyle Retterer, MS and Genomic Consultant, Audra Bettinelli, MS, CGC. The webinar is focused on updates in Next Generation Sequencing (NGS) and together they cover:

This webinar with Kyle Retterer of GeneDx, Inc. and Dekel Gelbman of FDNA, Inc. is focused on GeneDx’s recent advances using artificial intelligence to diagnose complex phenotypes and FDNA’s Face2Gene interface to help providers improve test utilization, diagnosis, and discovery.Disclaimer: Any statements by Mr. Gelbman are on behalf of FDNA, and GeneDx is not responsible for Mr. Gelbman’s statements, any positions of FDNA, or any of the participant questions or comments.

In celebration of having now sequenced the exomes of over 50,000 individuals, GeneDx invites you to join us for our Exome Sprint Series. This program will consist of three 30 minute webinar presentations followed by question and answer looking behind the scenes of our XomeDx program and what makes it so unique.

This program consists of two webinars covering an overview of the GeneDx processes, variant nomenclature, and factors to consider in variant classification as well as a review of the ACMG guidelines and patient cases.

Important Cookies Information – This message will only appear once. GeneDx, Inc., a subsidiary of Bio-Reference Laboratories, Inc. and OPKO websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.